PHI with concentric periaxial encephalomyelitis
How does this condition affect your private health insurance?
Encephalomyelitis periaxialis concentrica, also known as Balo's concentric sclerosis, is a rare and severe demyelinating disease of the central nervous system. Considered a variant of multiple sclerosis, it is pathologically characterized by distinct alternating layers of preserved and demyelinated white matter, forming a striking 'onion-skin' pattern visible on MRI. This aggressive condition typically presents with rapidly progressive neurological deficits, including motor weakness, sensory disturbances, visual impairment, ataxia, and cognitive decline, reflecting widespread white matter damage. The clinical course is frequently acute to subacute, often leading to significant disability or death within a relatively short period, though milder or remitting forms exist. Diagnosis relies heavily on characteristic imaging findings.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute to subacute, evolving over days to several weeks
Duration of Illness (Lifetime)
Often rapidly progressive, typically leading to significant disability or death within months to a few years; some cases may have a more prolonged or relapsing-remitting course.
Cost of Treatment (Initial)
High, involving hospitalization, extensive diagnostic imaging (MRI), cerebrospinal fluid analysis, high-dose corticosteroids, and potentially plasma exchange or intravenous immunoglobulins.
Cost of Treatment (Lifetime)
Very high, due to chronic management, potential use of disease-modifying therapies, extensive rehabilitation, long-term supportive care, and management of severe neurological deficits and complications.
Mortality Rate
Moderate to high, especially in acute, severe forms, with a significant risk of fatality within a few years of onset due to rapid progression and complications.
Risk of Secondary Damages
Very high, leading to severe and permanent neurological deficits including motor impairment, cognitive dysfunction, sensory loss, visual impairment, and bowel/bladder dysfunction, often resulting in complete dependency.
Probability of Full Recovery
Very low. While some improvement with treatment is possible, complete recovery without any residual neurological deficits is exceedingly rare.
Underlying Disease Risk
Low. While it is considered a variant of multiple sclerosis, indicating a shared underlying autoimmune demyelinating process, the probability of other distinct, unrelated underlying diseases occurring simultaneously is low.